UNICHEM LABORATORIES
Back to Balance Sheet
|
UNICHEM LABORATORIES Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹886 Cr | ₹992 Cr | ₹738 Cr | ₹640 Cr | ₹552 Cr |
What is the latest Total Current Liabilities ratio of UNICHEM LABORATORIES ?
| Year | Total Current Liabilities |
|---|---|
| Mar2026 | ₹886 Cr |
| Mar2025 | ₹992 Cr |
| Mar2024 | ₹738 Cr |
| Mar2023 | ₹640 Cr |
| Mar2022 | ₹552 Cr |
How is Total Current Liabilities of UNICHEM LABORATORIES Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹886 Cr | -10.69 | |
| Mar2025 | ₹992 Cr | 34.49 | |
| Mar2024 | ₹738 Cr | 15.32 | |
| Mar2023 | ₹640 Cr | 15.84 | |
| Mar2022 | ₹552 Cr | - | |
Compare Total Current Liabilities of peers of UNICHEM LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| UNICHEM LABORATORIES | ₹3,732.3 Cr | -3.1% | -2.3% | 8.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,067.0 Cr | -2.3% | -5.9% | 6.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,222.0 Cr | -1.7% | -1.1% | 60.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹177,974.0 Cr | -2.1% | -5.1% | 32.2% | Stock Analytics | |
| CIPLA | ₹107,447.0 Cr | -2.2% | -4% | -13.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,471.0 Cr | 1.8% | 7.6% | -4.3% | Stock Analytics | |
UNICHEM LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| UNICHEM LABORATORIES | -3.1% |
-2.3% |
8.7% |
| SENSEX | -0.6% |
-4.8% |
-11.4% |
You may also like the below Video Courses